why choose us

First received: August 02, 2023

Clinical Trial: Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetic Macular Edema

Study Type: INTERVENTIONAL


Official Title: A Phase 2b, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With

Brief Summary: The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Edema.The main questions the study aims to answer are:Assess the efficacy of foselutoclax compared to afliberceptAssess the safety and tolerability of foselutoclax

Read more